▶ 調査レポート

世界の犬用拡張型心筋症薬産業調査2019-2025
• 英文タイトル：Global Canine Dilated Cardiomyopathy Drug Industry Research Report, Growth Trends and Competitive Analysis 2019-2025

QYResearchが調査・発行した産業分析レポートです。世界の犬用拡張型心筋症薬産業調査2019-2025 / Global Canine Dilated Cardiomyopathy Drug Industry Research Report, Growth Trends and Competitive Analysis 2019-2025 / QYR9NV15385資料のイメージです。• レポートコード：QYR9NV15385
• 出版社/出版日：QYResearch / 2019年11月16日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、117ページ
• 納品方法：Eメール（受注後2-3営業日）
• 産業分類：医薬品・ヘルスケア
• 販売価格（消費税別）
  Single User￥735,000 (USD4,900)▷ お問い合わせ
  Enterprise License￥1,470,000 (USD9,800)▷ お問い合わせ
• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
※本調査レポートでは、世界の犬用拡張型心筋症薬市場について調査・分析し、市場規模、市場動向、市場予測（～2025年）、市場シェア、関連企業情報などを含め、以下の構成でお届け致します。犬用拡張型心筋症薬の種類別には、経口、注射剤に、用途別には、オンライン、オフラインに、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。

・調査レポートの概要
・グローバル成長傾向・産業動向
・企業別市場シェア
・犬用拡張型心筋症薬の種類別市場規模：経口、注射剤
・犬用拡張型心筋症薬の用途別市場規模：オンライン、オフライン
・犬用拡張型心筋症薬の地域別市場規模：北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ
・主要企業のプロフィール：C. H. Boehringer Sohn AG & Co.、KG, Merck & Co.、Dechra Pharmaceuticals PLC、Bayer AG、Orion、SAVA Vet、Elanco、Zoetis Inc.
・市場規模予測2019-2025：生産量
・市場規模予測2019-2025：消費量
・バリューチェーン・販売チャネル分析
・市場機会・課題分析
...

Canine dilated cardiomyopathy drugs are used to treat heart muscle diseases which causes the heart to weaken and enlarge. This results in weaken contraction and poor pumping ability of the heart. The canine dilated cardiomyopathy is prevalent in certain breeds of dog and observed to be rare in crossbreeds dogs. Canine dilated cardiomyopathy drugs are directed at enhancing systolic (pump) function of the heart, dilating the peripheral blood vessels to lower ventricular workload, controlling heart rate and cardiac arrhythmias. Canine dilated cardiomyopathy drugs treatment goals are achieved by the administration of cardiac medication which may be delivered through injections in an emergency situation or orally in stable animals.In 2018, the global Canine Dilated Cardiomyopathy Drug market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2019. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Canine Dilated Cardiomyopathy Drug.

This study researches the market size of Canine Dilated Cardiomyopathy Drug, presents the global Canine Dilated Cardiomyopathy Drug sales and revenue by companies, regions, type and application, history breakdown data from 2014 to 2019, and forecast to 2025.
This report focuses on the key data information of Canine Dilated Cardiomyopathy Drug in key regions like North America, Europe, China and Japan, presents sales, revenue, market share, growth rate of Canine Dilated Cardiomyopathy Drug for each region and countries in each region.
For top companies, this report investigates and analyzes the sales, revenue, market share and growth rate for the top players, key data from 2014 to 2019.
This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter’s Five Forces Analysis.

This report includes the following manufacturers; we can also add the other companies as you want.
KG, Merck & Co.
Dechra Pharmaceuticals PLC
Bayer AG
Orion
SAVA Vet
Elanco
Zoetis Inc.

Market Segment by Product Type
Oral
Injectable

Market Segment by Application
Online
Offline

Market size split by Region
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Central & South America
Brazil
Middle East & Africa
Turkey
GCC Countries
Egypt
South Africa

The study objectives are:
To analyze and research the global Canine Dilated Cardiomyopathy Drug status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
To present the key Canine Dilated Cardiomyopathy Drug manufacturers, capacity, production, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Canine Dilated Cardiomyopathy Drug are as follows:
History Year: 2014-2019
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

レポート目次

Table of Contents

1 Report Overview
1.1 Research Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Canine Dilated Cardiomyopathy Drug Market Size Growth Rate by Type
1.3.2 Oral
1.3.3 Injectable
1.4 Market Segment by Application
1.4.1 Global Canine Dilated Cardiomyopathy Drug Market Share by Application (2019-2025)
1.4.2 Online
1.4.3 Offline
1.5 Study Objectives
1.6 Years Considered

2 Global Growth Trends
2.1 Global Canine Dilated Cardiomyopathy Drug Market Size
2.1.1 Global Canine Dilated Cardiomyopathy Drug Revenue 2014-2025
2.1.2 Global Canine Dilated Cardiomyopathy Drug Sales 2014-2025
2.2 Canine Dilated Cardiomyopathy Drug Growth Rate by Regions
2.2.1 Global Canine Dilated Cardiomyopathy Drug Sales by Regions 2014-2019
2.2.2 Global Canine Dilated Cardiomyopathy Drug Revenue by Regions 2014-2019
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers

3 Market Share by Manufacturers
3.1 Canine Dilated Cardiomyopathy Drug Sales by Manufacturers
3.1.1 Canine Dilated Cardiomyopathy Drug Sales by Manufacturers 2014-2019
3.1.2 Canine Dilated Cardiomyopathy Drug Sales Market Share by Manufacturers 2014-2019
3.2 Revenue by Manufacturers
3.2.1 Canine Dilated Cardiomyopathy Drug Revenue by Manufacturers (2014-2019)
3.2.2 Canine Dilated Cardiomyopathy Drug Revenue Share by Manufacturers (2014-2019)
3.2.3 Global Canine Dilated Cardiomyopathy Drug Market Concentration Ratio (CR5 and HHI)
3.3 Canine Dilated Cardiomyopathy Drug Price by Manufacturers
3.4 Key Manufacturers Canine Dilated Cardiomyopathy Drug Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Canine Dilated Cardiomyopathy Drug Market
3.6 Key Manufacturers Canine Dilated Cardiomyopathy Drug Product Offered
3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Oral Sales and Revenue (2014-2019)
4.1.2 Injectable Sales and Revenue (2014-2019)
4.2 Global Canine Dilated Cardiomyopathy Drug Sales Market Share by Type
4.3 Global Canine Dilated Cardiomyopathy Drug Revenue Market Share by Type
4.4 Canine Dilated Cardiomyopathy Drug Price by Type

5 Market Size by Application
5.1 Overview
5.1 Global Canine Dilated Cardiomyopathy Drug Sales by Application

6 North America
6.1 North America Canine Dilated Cardiomyopathy Drug Breakdown Data by Company
6.2 North America Canine Dilated Cardiomyopathy Drug Breakdown Data by Type
6.3 North America Canine Dilated Cardiomyopathy Drug Breakdown Data by Application
6.4 North America Canine Dilated Cardiomyopathy Drug Breakdown Data by Countries
6.4.1 North America Canine Dilated Cardiomyopathy Drug Sales by Countries
6.4.2 North America Canine Dilated Cardiomyopathy Drug Revenue by Countries
6.4.3 United States
6.4.4 Canada
6.4.5 Mexico

7 Europe
7.1 Europe Canine Dilated Cardiomyopathy Drug Breakdown Data by Company
7.2 Europe Canine Dilated Cardiomyopathy Drug Breakdown Data by Type
7.3 Europe Canine Dilated Cardiomyopathy Drug Breakdown Data by Application
7.4 Europe Canine Dilated Cardiomyopathy Drug Breakdown Data by Countries
7.4.1 Europe Canine Dilated Cardiomyopathy Drug Sales by Countries
7.4.2 Europe Canine Dilated Cardiomyopathy Drug Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 UK
7.4.6 Italy
7.4.7 Russia

8 Asia Pacific
8.1 Asia Pacific Canine Dilated Cardiomyopathy Drug Breakdown Data by Company
8.2 Asia Pacific Canine Dilated Cardiomyopathy Drug Breakdown Data by Type
8.3 Asia Pacific Canine Dilated Cardiomyopathy Drug Breakdown Data by Application
8.4 Asia Pacific Canine Dilated Cardiomyopathy Drug Breakdown Data by Regions
8.4.1 Asia Pacific Canine Dilated Cardiomyopathy Drug Sales by Countries
8.4.2 Asia Pacific Canine Dilated Cardiomyopathy Drug Revenue by Countries
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Indonesia
8.4.9 Thailand
8.4.10 Malaysia
8.4.11 Philippines
8.4.12 Vietnam

9 Central & South America
9.1 Central & South America Canine Dilated Cardiomyopathy Drug Breakdown Data by Company
9.2 Central & South America Canine Dilated Cardiomyopathy Drug Breakdown Data by Type
9.3 Central & South America Canine Dilated Cardiomyopathy Drug Breakdown Data by Application
9.4 Central & South America Canine Dilated Cardiomyopathy Drug Breakdown Data by Countries
9.4.1 Central & South America Canine Dilated Cardiomyopathy Drug Sales by Countries
9.4.2 Central & South America Canine Dilated Cardiomyopathy Drug Revenue by Countries
9.4.3 Brazil

10 Middle East and Africa
10.1 Middle East and Africa Canine Dilated Cardiomyopathy Drug Breakdown Data by Type
10.2 Middle East and Africa Canine Dilated Cardiomyopathy Drug Breakdown Data by Application
10.3 Middle East and Africa Canine Dilated Cardiomyopathy Drug Breakdown Data by Countries
10.3.1 Middle East and Africa Canine Dilated Cardiomyopathy Drug Sales by Countries
10.3.2 Middle East and Africa Canine Dilated Cardiomyopathy Drug Revenue by Countries
10.3.3 Turkey
10.3.4 GCC Countries
10.3.5 Egypt
10.3.6 South Africa

11 Company Profiles
11.1 C. H. Boehringer Sohn AG & Co.
11.1.1 C. H. Boehringer Sohn AG & Co. Company Details
11.1.2 Company Description and Business Overview
11.1.3 Sales, Revenue and Market Share of Canine Dilated Cardiomyopathy Drug
11.1.4 Canine Dilated Cardiomyopathy Drug Product Introduction
11.1.5 C. H. Boehringer Sohn AG & Co. Recent Development
11.2 KG, Merck & Co.
11.2.1 KG, Merck & Co. Company Details
11.2.2 Company Description and Business Overview
11.2.3 Sales, Revenue and Market Share of Canine Dilated Cardiomyopathy Drug
11.2.4 Canine Dilated Cardiomyopathy Drug Product Introduction
11.2.5 KG, Merck & Co. Recent Development
11.3 Dechra Pharmaceuticals PLC
11.3.1 Dechra Pharmaceuticals PLC Company Details
11.3.2 Company Description and Business Overview
11.3.3 Sales, Revenue and Market Share of Canine Dilated Cardiomyopathy Drug
11.3.4 Canine Dilated Cardiomyopathy Drug Product Introduction
11.3.5 Dechra Pharmaceuticals PLC Recent Development
11.4 Bayer AG
11.4.1 Bayer AG Company Details
11.4.2 Company Description and Business Overview
11.4.3 Sales, Revenue and Market Share of Canine Dilated Cardiomyopathy Drug
11.4.4 Canine Dilated Cardiomyopathy Drug Product Introduction
11.4.5 Bayer AG Recent Development
11.5 Orion
11.5.1 Orion Company Details
11.5.2 Company Description and Business Overview
11.5.3 Sales, Revenue and Market Share of Canine Dilated Cardiomyopathy Drug
11.5.4 Canine Dilated Cardiomyopathy Drug Product Introduction
11.5.5 Orion Recent Development
11.6 SAVA Vet
11.6.1 SAVA Vet Company Details
11.6.2 Company Description and Business Overview
11.6.3 Sales, Revenue and Market Share of Canine Dilated Cardiomyopathy Drug
11.6.4 Canine Dilated Cardiomyopathy Drug Product Introduction
11.6.5 SAVA Vet Recent Development
11.7 Elanco
11.7.1 Elanco Company Details
11.7.2 Company Description and Business Overview
11.7.3 Sales, Revenue and Market Share of Canine Dilated Cardiomyopathy Drug
11.7.4 Canine Dilated Cardiomyopathy Drug Product Introduction
11.7.5 Elanco Recent Development
11.8 Zoetis Inc.
11.8.1 Zoetis Inc. Company Details
11.8.2 Company Description and Business Overview
11.8.3 Sales, Revenue and Market Share of Canine Dilated Cardiomyopathy Drug
11.8.4 Canine Dilated Cardiomyopathy Drug Product Introduction
11.8.5 Zoetis Inc. Recent Development

12 Value Chain and Sales Channels Analysis
12.1 Value Chain Analysis
12.2 Sales Channels Analysis
12.2.1 Canine Dilated Cardiomyopathy Drug Sales Channels
12.2.2 Canine Dilated Cardiomyopathy Drug Distributors
12.3 Canine Dilated Cardiomyopathy Drug Customers

13 Market Forecast
13.1 Global Canine Dilated Cardiomyopathy Drug Sales and Revenue Forecast 2019-2025
13.2 Global Canine Dilated Cardiomyopathy Drug Sales Forecast by Type
13.3 Global Canine Dilated Cardiomyopathy Drug Sales Forecast by Application
13.4 Canine Dilated Cardiomyopathy Drug Forecast by Regions
13.4.1 Global Canine Dilated Cardiomyopathy Drug Sales Forecast by Regions 2019-2025
13.4.2 Global Canine Dilated Cardiomyopathy Drug Revenue Forecast by Regions 2019-2025
13.5 North America Market Forecast
13.5.1 North America Canine Dilated Cardiomyopathy Drug Forecast by Countries 2019-2025
13.5.2 United States
13.5.3 Canada
13.5.4 Mexico
13.6 Europe Market Forecast
13.6.1 Europe Canine Dilated Cardiomyopathy Drug Forecast by Countries 2019-2025
13.6.2 Germany
13.6.3 France
13.6.4 UK
13.6.5 Italy
13.6.6 Russia
13.7 Asia Pacific Market Forecast
13.7.1 Asia Pacific Canine Dilated Cardiomyopathy Drug Sales Forecast by Regions 2019-2025
13.7.2 China
13.7.3 Japan
13.7.4 South Korea
13.7.5 India
13.7.6 Australia
13.7.7 Indonesia
13.7.8 Thailand
13.7.9 Malaysia
13.7.10 Philippines
13.7.11 Vietnam
13.8 Central & South America Market Forecast
13.8.1 Central & South America Canine Dilated Cardiomyopathy Drug Sales Forecast by Countries 2019-2025
13.8.2 Brazil
13.9 Middle East and Africa Market Forecast
13.9.1 Middle East and Africa Canine Dilated Cardiomyopathy Drug Sales Forecast by Countries 2019-2025
13.9.2 Turkey
13.9.3 GCC Countries
13.9.4 Egypt
13.9.5 South Africa

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer

List of Tables and Figures

Figure Canine Dilated Cardiomyopathy Drug Product Picture
Table Canine Dilated Cardiomyopathy Drug Key Market Segments
Table Major Manufacturers Canine Dilated Cardiomyopathy Drug Covered in This Report
Table Global Canine Dilated Cardiomyopathy Drug Market Size Growth Rate by Type 2019-2025 (MT) & (Million US$)
Figure Global Canine Dilated Cardiomyopathy Drug Sales Market Shar by Type 2014-2025
Figure Oral Figures
Table Major Manufacturers of Oral
Figure Injectable Figures
Table Major Manufacturers of Injectable
Table Global Canine Dilated Cardiomyopathy Drug Market Share by Application 2019-2025 (MT)
Figure Online Use Case
Figure Offline Use Case
Figure Canine Dilated Cardiomyopathy Drug Report Years Considered
Figure Global Canine Dilated Cardiomyopathy Drug Market Size 2014-2025 (Million US$)
Figure Global Canine Dilated Cardiomyopathy Drug Sales 2014-2019 (MT)
Table Global Canine Dilated Cardiomyopathy Drug Market Size by Regions 2014-2019 (MT) & (Million US$)
Table Global Canine Dilated Cardiomyopathy Drug Sales by Regions 2014-2019 (MT)
Table Global Canine Dilated Cardiomyopathy Drug Sales Market Share by Regions 2014-2019
Figure Global Canine Dilated Cardiomyopathy Drug Sales Market Share by Regions 2014-2019
Figure Global Canine Dilated Cardiomyopathy Drug Sales Market Share by Regions in 2018
Table Global Canine Dilated Cardiomyopathy Drug Revenue by Regions 2014-2019 (Million US$)
Table Global Canine Dilated Cardiomyopathy Drug Revenue Market Share by Regions 2014-2019
Figure Global Canine Dilated Cardiomyopathy Drug Revenue Market Share by Regions 2014-2019
Figure Global Canine Dilated Cardiomyopathy Drug Revenue Market Share by Regions in 2018
Table Market Top Trends
Table Global Canine Dilated Cardiomyopathy Drug Sales by Manufacturers (2014-2019) (MT)
Table Global Canine Dilated Cardiomyopathy Drug Sales Share by Manufacturers (2014-2019)
Figure Global Canine Dilated Cardiomyopathy Drug Sales Share by Manufacturers in 2018
Table Canine Dilated Cardiomyopathy Drug Revenue by Manufacturers (2014-2019) (Million USD)
Table Canine Dilated Cardiomyopathy Drug Revenue Share by Manufacturers (2014-2019)
Figure Canine Dilated Cardiomyopathy Drug Value Share by Manufacturers in 2018
Table Global Canine Dilated Cardiomyopathy Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Canine Dilated Cardiomyopathy Drug Price (2014-2019) (USD/Kg)
Table Key Manufacturers Canine Dilated Cardiomyopathy Drug Plants/Factories Distribution
Table Key Manufacturers Canine Dilated Cardiomyopathy Drug Area Served
Table Date of Key Manufacturers Enter into Canine Dilated Cardiomyopathy Drug Market
Table Key Manufacturers Canine Dilated Cardiomyopathy Drug Product Type
Table Mergers & Acquisitions, Expansion Plans
Table Global Oral Sales an目录输出!D Revenue (2014-2019) (MT) & (Million US$)
Table Global Injectable Sales an目录输出!D Revenue (2014-2019) (MT) & (Million US$)
Table Global Canine Dilated Cardiomyopathy Drug Sales by Type (2014-2019) (MT)
Table Global Canine Dilated Cardiomyopathy Drug Sales Share by Type (2014-2019)
Figure Global Canine Dilated Cardiomyopathy Drug Sales Market Share by Type (2014-2019)
Figure Global Canine Dilated Cardiomyopathy Drug Sales Market Share by Type in 2018
Table Global Canine Dilated Cardiomyopathy Drug Revenue by Type (2014-2019) (Million US$)
Table Global Canine Dilated Cardiomyopathy Drug Revenue Share by Type (2014-2019)
Figure Global Canine Dilated Cardiomyopathy Drug Revenue Market Share by Type (2014-2019)
Figure Global Canine Dilated Cardiomyopathy Drug Revenue Market Share by Type in 2018
Table Canine Dilated Cardiomyopathy Drug Price by Type 2014-2019 (USD/Kg)
Table Global Canine Dilated Cardiomyopathy Drug Sales by Application (2014-2019) (MT)
Table Global Canine Dilated Cardiomyopathy Drug Sales Share by Application (2014-2019)
Figure Global Sales Canine Dilated Cardiomyopathy Drug Market Share by Application (2014-2019)
Figure Global Sales Canine Dilated Cardiomyopathy Drug Market Share by Application in 2018
Figure North America Canine Dilated Cardiomyopathy Drug Sales Growth Rate 2014-2019 (MT)
Figure North America Canine Dilated Cardiomyopathy Drug Revenue Growth Rate 2014-2019 (Million US$)
Table North America Canine Dilated Cardiomyopathy Drug Sales by Company (2014-2019) (MT)
Table North America Canine Dilated Cardiomyopathy Drug Sales Market Share by Company (2014-2019)
Figure North America Canine Dilated Cardiomyopathy Drug Sales Market Share by Company in 2018
Table North America Canine Dilated Cardiomyopathy Drug Sales by Type (2014-2019) (MT)
Table North America Canine Dilated Cardiomyopathy Drug Sales Market Share by Type (2014-2019)
Figure North America Canine Dilated Cardiomyopathy Drug Market Share by Type in 2018
Table North America Canine Dilated Cardiomyopathy Drug Sales by Application (2014-2019) (MT)
Table North America Canine Dilated Cardiomyopathy Drug Sales Market Share by Application (2014-2019)
Figure North America Canine Dilated Cardiomyopathy Drug Market Share by Application in 2018
Table North America Canine Dilated Cardiomyopathy Drug Sales by Countries (2014-2019) (MT)
Table North America Canine Dilated Cardiomyopathy Drug Sales Market Share by Countries (2014-2019)
Figure North America Canine Dilated Cardiomyopathy Drug Sales Market Share by Countries in 2018
Table North America Canine Dilated Cardiomyopathy Drug Revenue by Countries (2014-2019) (Million US$)
Table North America Canine Dilated Cardiomyopathy Drug Revenue Market Share by Countries (2014-2019)
Figure North America Canine Dilated Cardiomyopathy Drug Revenue Market Share by Countries in 2018
Figure United States Canine Dilated Cardiomyopathy Drug Sales Growth Rate (2014-2019) (MT)
Figure Canada Canine Dilated Cardiomyopathy Drug Sales Growth Rate (2014-2019) (MT)
Figure Mexico Canine Dilated Cardiomyopathy Drug Sales Growth Rate (2014-2019) (MT)
Figure Europe Canine Dilated Cardiomyopathy Drug Sales Growth Rate 2014-2019 (MT)
Figure Europe Canine Dilated Cardiomyopathy Drug Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Canine Dilated Cardiomyopathy Drug Sales by Company (2014-2019) (MT)
Table Europe Canine Dilated Cardiomyopathy Drug Sales Market Share by Company (2014-2019)
Figure Europe Canine Dilated Cardiomyopathy Drug Sales Market Share by Company in 2018
Table Europe Canine Dilated Cardiomyopathy Drug Sales by Type (2014-2019) (MT)
Table Europe Canine Dilated Cardiomyopathy Drug Sales Market Share by Type (2014-2019)
Figure Europe Canine Dilated Cardiomyopathy Drug Sales Market Share by Type in 2018
Table Europe Canine Dilated Cardiomyopathy Drug Sales by Application (2014-2019) (MT)
Table Europe Canine Dilated Cardiomyopathy Drug Sales Market Share by Application (2014-2019)
Figure Europe Canine Dilated Cardiomyopathy Drug Sales Market Share by Application in 2018
Table Europe Canine Dilated Cardiomyopathy Drug Sales by Countries (2014-2019) (MT)
Table Europe Canine Dilated Cardiomyopathy Drug Sales Market Share by Countries (2014-2019)
Figure Europe Canine Dilated Cardiomyopathy Drug Sales Market Share by Countries in 2018
Table Europe Canine Dilated Cardiomyopathy Drug Revenue by Countries (2014-2019) (Million US$)
Table Europe Canine Dilated Cardiomyopathy Drug Revenue Market Share by Countries (2014-2019)
Figure Europe Canine Dilated Cardiomyopathy Drug Revenue Market Share by Countries in 2018
Figure Germany Canine Dilated Cardiomyopathy Drug Sales Growth Rate (2014-2019) (MT)
Figure France Canine Dilated Cardiomyopathy Drug Sales Growth Rate (2014-2019) (MT)
Figure UK Canine Dilated Cardiomyopathy Drug Sales Growth Rate (2014-2019) (MT)
Figure Italy Canine Dilated Cardiomyopathy Drug Sales Growth Rate (2014-2019) (MT)
Figure Russia Canine Dilated Cardiomyopathy Drug Sales Growth Rate (2014-2019) (MT)
Figure Asia Pacific Canine Dilated Cardiomyopathy Drug Sales Growth Rate 2014-2019 (MT)
Figure Asia Pacific Canine Dilated Cardiomyopathy Drug Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Canine Dilated Cardiomyopathy Drug Sales by Regions (2014-2019) (MT)
Table Asia Pacific Canine Dilated Cardiomyopathy Drug Sales Market Share by Regions (2014-2019)
Figure Asia Pacific Canine Dilated Cardiomyopathy Drug Sales Market Share by Regions in 2018
Table Asia Pacific Canine Dilated Cardiomyopathy Drug Sales by Type (2014-2019) (MT)
Table Asia Pacific Canine Dilated Cardiomyopathy Drug Sales Market Share by Type (2014-2019)
Figure Asia Pacific Canine Dilated Cardiomyopathy Drug Market Share by Type in 2018
Table Asia Pacific Canine Dilated Cardiomyopathy Drug Sales by Application (2014-2019) (MT)
Table Asia Pacific Canine Dilated Cardiomyopathy Drug Sales Market Share by Application (2014-2019)
Figure Asia Pacific Canine Dilated Cardiomyopathy Drug Market Share by Application in 2018
Table Asia Pacific Canine Dilated Cardiomyopathy Drug Sales by Countries (2014-2019) (MT)
Table Asia Pacific Canine Dilated Cardiomyopathy Drug Sales Market Share by Regions (2014-2019)
Figure Asia Pacific Canine Dilated Cardiomyopathy Drug Sales Market Share by Regions in 2018
Table Asia Pacific Canine Dilated Cardiomyopathy Drug Revenue by Regions (2014-2019) (Million US$)
Table Asia Pacific Canine Dilated Cardiomyopathy Drug Revenue Market Share by Regions (2014-2019)
Figure Asia Pacific Canine Dilated Cardiomyopathy Drug Revenue Market Share by Regions in 2018
Figure China Canine Dilated Cardiomyopathy Drug Sales Growth Rate (2014-2019) (MT)
Figure China Canine Dilated Cardiomyopathy Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Canine Dilated Cardiomyopathy Drug Sales Growth Rate (2014-2019) (MT)
Figure Japan Canine Dilated Cardiomyopathy Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Canine Dilated Cardiomyopathy Drug Sales Growth Rate (2014-2019) (MT)
Figure Korea Canine Dilated Cardiomyopathy Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure India Canine Dilated Cardiomyopathy Drug Sales Growth Rate (2014-2019) (MT)
Figure India Canine Dilated Cardiomyopathy Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Canine Dilated Cardiomyopathy Drug Sales Growth Rate (2014-2019) (MT)
Figure Australia Canine Dilated Cardiomyopathy Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Canine Dilated Cardiomyopathy Drug Sales Growth Rate (2014-2019) (MT)
Figure Indonesia Canine Dilated Cardiomyopathy Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Canine Dilated Cardiomyopathy Drug Sales Growth Rate (2014-2019) (MT)
Figure Malaysia Canine Dilated Cardiomyopathy Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Canine Dilated Cardiomyopathy Drug Sales Growth Rate (2014-2019) (MT)
Figure Philippines Canine Dilated Cardiomyopathy Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Canine Dilated Cardiomyopathy Drug Sales Growth Rate (2014-2019) (MT)
Figure Thailand Canine Dilated Cardiomyopathy Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Canine Dilated Cardiomyopathy Drug Sales Growth Rate (2014-2019) (MT)
Figure Vietnam Canine Dilated Cardiomyopathy Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Central & South America Canine Dilated Cardiomyopathy Drug Sales Growth Rate 2014-2019 (MT)
Figure Central & South America Canine Dilated Cardiomyopathy Drug Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Canine Dilated Cardiomyopathy Drug Sales by Company (2014-2019) (MT)
Table Central & South America Canine Dilated Cardiomyopathy Drug Sales Market Share by Company (2014-2019)
Figure Central & South America Canine Dilated Cardiomyopathy Drug Sales Market Share by Company in 2018
Table Central & South America Canine Dilated Cardiomyopathy Drug Sales by Type (2014-2019) (MT)
Table Central & South America Canine Dilated Cardiomyopathy Drug Sales Market Share by Type (2014-2019)
Figure Central & South America Canine Dilated Cardiomyopathy Drug Market Share by Type in 2018
Table Central & South America Canine Dilated Cardiomyopathy Drug Sales by Application (2014-2019) (MT)
Table Central & South America Canine Dilated Cardiomyopathy Drug Sales Market Share by Application (2014-2019)
Figure Central & South America Canine Dilated Cardiomyopathy Drug Market Share by Application in 2018
Table Central & South America Canine Dilated Cardiomyopathy Drug Sales by Countries (2014-2019) (MT)
Table Central & South America Canine Dilated Cardiomyopathy Drug Sales Market Share by Countries (2014-2019)
Figure Central & South America Canine Dilated Cardiomyopathy Drug Sales Market Share by Countries in 2018
Table Central & South America Canine Dilated Cardiomyopathy Drug Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Canine Dilated Cardiomyopathy Drug Revenue Market Share by Countries (2014-2019)
Figure Central & South America Canine Dilated Cardiomyopathy Drug Revenue Market Share by Countries in 2018
Figure Brazil Canine Dilated Cardiomyopathy Drug Sales Growth Rate (2014-2019) (MT)
Figure Brazil Canine Dilated Cardiomyopathy Drug Revenue Growth Rate (2014-2019) (MT)
Figure Middle East and Africa Canine Dilated Cardiomyopathy Drug Sales Growth Rate 2014-2019 (MT)
Figure Middle East and Africa Canine Dilated Cardiomyopathy Drug Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Canine Dilated Cardiomyopathy Drug Sales by Type (2014-2019) (MT)
Table Middle East and Africa Canine Dilated Cardiomyopathy Drug Sales Market Share by Type (2014-2019)
Figure Middle East and Africa Canine Dilated Cardiomyopathy Drug Sales Market Share by Type in 2018
Table Middle East and Africa Canine Dilated Cardiomyopathy Drug Sales by Application (2014-2019) (MT)
Table Middle East and Africa Canine Dilated Cardiomyopathy Drug Sales Market Share by Application (2014-2019)
Figure Middle East and Africa Canine Dilated Cardiomyopathy Drug Sales Market Share by Application in 2018
Table Middle East and Africa Canine Dilated Cardiomyopathy Drug Sales by Countries (2014-2019) (MT)
Table Middle East and Africa Canine Dilated Cardiomyopathy Drug Sales Market Share by Countries (2014-2019)
Figure Middle East and Africa Canine Dilated Cardiomyopathy Drug Sales Market Share by Countries in 2018
Table Middle East and Africa Canine Dilated Cardiomyopathy Drug Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Canine Dilated Cardiomyopathy Drug Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Canine Dilated Cardiomyopathy Drug Revenue Market Share by Countries in 2018
Figure GCC Countries Canine Dilated Cardiomyopathy Drug Sales Growth Rate (2014-2019) (MT)
Figure GCC Countries Canine Dilated Cardiomyopathy Drug Revenue Growth Rate (2014-2019) (MT)
Figure Egypt Canine Dilated Cardiomyopathy Drug Sales Growth Rate (2014-2019) (MT)
Figure Egypt Canine Dilated Cardiomyopathy Drug Revenue Growth Rate (2014-2019) (MT)
Figure South Africa Canine Dilated Cardiomyopathy Drug Sales Growth Rate (2014-2019) (MT)
Figure South Africa Canine Dilated Cardiomyopathy Drug Revenue Growth Rate (2014-2019) (MT)
Table C. H. Boehringer Sohn AG & Co. Company Details
Table C. H. Boehringer Sohn AG & Co. Description and Business Overview
Table C. H. Boehringer Sohn AG & Co. Canine Dilated Cardiomyopathy Drug Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2014-2019)
Table C. H. Boehringer Sohn AG & Co. Canine Dilated Cardiomyopathy Drug Sales Growth Rate (2014-2019)
Table C. H. Boehringer Sohn AG & Co. Canine Dilated Cardiomyopathy Drug Sales Market Share in Global Market
Table C. H. Boehringer Sohn AG & Co. Recent Development
Table KG, Merck & Co. Company Details
Table KG, Merck & Co. Description and Business Overview
Table KG, Merck & Co. Canine Dilated Cardiomyopathy Drug Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2014-2019)
Table KG, Merck & Co. Canine Dilated Cardiomyopathy Drug Sales Growth Rate (2014-2019)
Table KG, Merck & Co. Canine Dilated Cardiomyopathy Drug Sales Market Share in Global Market
Table KG, Merck & Co. Recent Development
Table Dechra Pharmaceuticals PLC Company Details
Table Dechra Pharmaceuticals PLC Description and Business Overview
Table Dechra Pharmaceuticals PLC Canine Dilated Cardiomyopathy Drug Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2014-2019)
Table Dechra Pharmaceuticals PLC Canine Dilated Cardiomyopathy Drug Sales Growth Rate (2014-2019)
Table Dechra Pharmaceuticals PLC Canine Dilated Cardiomyopathy Drug Sales Market Share in Global Market
Table Dechra Pharmaceuticals PLC Recent Development
Table Bayer AG Company Details
Table Bayer AG Description and Business Overview
Table Bayer AG Canine Dilated Cardiomyopathy Drug Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2014-2019)
Table Bayer AG Canine Dilated Cardiomyopathy Drug Sales Growth Rate (2014-2019)
Table Bayer AG Canine Dilated Cardiomyopathy Drug Sales Market Share in Global Market
Table Bayer AG Recent Development
Table Orion Company Details
Table Orion Description and Business Overview
Table Orion Canine Dilated Cardiomyopathy Drug Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2014-2019)
Table Orion Canine Dilated Cardiomyopathy Drug Sales Growth Rate (2014-2019)
Table Orion Canine Dilated Cardiomyopathy Drug Sales Market Share in Global Market
Table Orion Recent Development
Table SAVA Vet Company Details
Table SAVA Vet Description and Business Overview
Table SAVA Vet Canine Dilated Cardiomyopathy Drug Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2014-2019)
Table SAVA Vet Canine Dilated Cardiomyopathy Drug Sales Growth Rate (2014-2019)
Table SAVA Vet Canine Dilated Cardiomyopathy Drug Sales Market Share in Global Market
Table SAVA Vet Recent Development
Table Elanco Company Details
Table Elanco Description and Business Overview
Table Elanco Canine Dilated Cardiomyopathy Drug Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2014-2019)
Table Elanco Canine Dilated Cardiomyopathy Drug Sales Growth Rate (2014-2019)
Table Elanco Canine Dilated Cardiomyopathy Drug Sales Market Share in Global Market
Table Elanco Recent Development
Table Zoetis Inc. Company Details
Table Zoetis Inc. Description and Business Overview
Table Zoetis Inc. Canine Dilated Cardiomyopathy Drug Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2014-2019)
Table Zoetis Inc. Canine Dilated Cardiomyopathy Drug Sales Growth Rate (2014-2019)
Table Zoetis Inc. Canine Dilated Cardiomyopathy Drug Sales Market Share in Global Market
Table Zoetis Inc. Recent Development
Figure Canine Dilated Cardiomyopathy Drug Value Chain
Table Canine Dilated Cardiomyopathy Drug Distributors List
Table Canine Dilated Cardiomyopathy Drug Customers List
Table Global Canine Dilated Cardiomyopathy Drug Sales Forecast 2019-2025 (MT) & (Million US$)
Figure Global Canine Dilated Cardiomyopathy Drug Sales Forecast 2019-2025 (MT)
Figure Global Canine Dilated Cardiomyopathy Drug Revenue Forecast 2019-2025 (Million US$)
Table Global Canine Dilated Cardiomyopathy Drug Sales Forecast by Type 2019-2025 (MT)
Figure Global Canine Dilated Cardiomyopathy Drug Sales Forecast by Type 2019-2025 (MT)
Figure Global Canine Dilated Cardiomyopathy Drug Sales Market Share Forecast by Type 2019-2025
Table Global Canine Dilated Cardiomyopathy Drug Sales Forecast by Application 2019-2025 (MT)
Figure Global Canine Dilated Cardiomyopathy Drug Sales Forecast by Application 2019-2025 (MT)
Figure Global Canine Dilated Cardiomyopathy Drug Sales Market Share Forecast by Application 2019-2025
Table Global Canine Dilated Cardiomyopathy Drug Sales Forecast by Regions 2019-2025 (MT)
Figure Global Canine Dilated Cardiomyopathy Drug Sales Forecast by Regions 2019-2025 (MT)
Figure Global Canine Dilated Cardiomyopathy Drug Sales Market Share Forecast by Regions 2019-2025
Table Global Canine Dilated Cardiomyopathy Drug Revenue Forecast by Regions 2019-2025 (Million US$)
Figure Global Canine Dilated Cardiomyopathy Drug Revenue Forecast by Regions 2019-2025 (Million US$)
Figure Global Canine Dilated Cardiomyopathy Drug Revenue Market Share Forecast by Regions 2019-2025
Table North America Canine Dilated Cardiomyopathy Drug Sales Forecast by Countries 2019-2025 (MT)
Table North America Canine Dilated Cardiomyopathy Drug Sales Market Share Forecast by Countries 2019-2025
Table North America Canine Dilated Cardiomyopathy Drug Revenue Forecast by Countries 2019-2025 (Million US$)
Table North America Canine Dilated Cardiomyopathy Drug Revenue Market Share Forecast by Countries 2019-2025
Figure United States Canine Dilated Cardiomyopathy Drug Sales Forecast 2019-2025 (MT)
Figure Canada Canine Dilated Cardiomyopathy Drug Sales Forecast 2019-2025 (MT)
Figure Mexico Canine Dilated Cardiomyopathy Drug Sales Forecast 2019-2025 (MT)
Table Europe Canine Dilated Cardiomyopathy Drug Sales Forecast by Countries 2019-2025 (MT)
Table Europe Canine Dilated Cardiomyopathy Drug Sales Market Share Forecast by Countries 2019-2025
Table Europe Canine Dilated Cardiomyopathy Drug Revenue Forecast by Countries 2019-2025 (Million US$)
Table Europe Canine Dilated Cardiomyopathy Drug Revenue Market Share Forecast by Countries 2019-2025
Figure Germany Canine Dilated Cardiomyopathy Drug Sales Forecast 2019-2025 (MT)
Figure France Canine Dilated Cardiomyopathy Drug Sales Forecast 2019-2025 (MT)
Figure UK Canine Dilated Cardiomyopathy Drug Sales Forecast 2019-2025 (MT)
Figure Italy Canine Dilated Cardiomyopathy Drug Sales Forecast 2019-2025 (MT)
Figure Russia Canine Dilated Cardiomyopathy Drug Sales Forecast 2019-2025 (MT)
Table Asia Pacific Canine Dilated Cardiomyopathy Drug Sales Forecast by Regions 2019-2025 (MT)
Table Asia Pacific Canine Dilated Cardiomyopathy Drug Sales Market Share Forecast by Regions 2019-2025
Table Asia Pacific Canine Dilated Cardiomyopathy Drug Revenue Forecast by Regions 2019-2025 (Million US$)
Table Asia Pacific Canine Dilated Cardiomyopathy Drug Revenue Market Share Forecast by Regions 2019-2025
Figure China Canine Dilated Cardiomyopathy Drug Sales Forecast 2019-2025 (MT)
Figure Japan Canine Dilated Cardiomyopathy Drug Sales Forecast 2019-2025 (MT)
Figure South Korea Canine Dilated Cardiomyopathy Drug Sales Forecast 2019-2025 (MT)
Figure India Canine Dilated Cardiomyopathy Drug Sales Forecast 2019-2025 (MT)
Figure Australia Canine Dilated Cardiomyopathy Drug Sales Forecast 2019-2025 (MT)
Figure Indonesia Canine Dilated Cardiomyopathy Drug Sales Forecast 2019-2025 (MT)
Figure Thailand Canine Dilated Cardiomyopathy Drug Sales Forecast 2019-2025 (MT)
Figure Malaysia Canine Dilated Cardiomyopathy Drug Sales Forecast 2019-2025 (MT)
Figure Philippines Canine Dilated Cardiomyopathy Drug Sales Forecast 2019-2025 (MT)
Figure Vietnam Canine Dilated Cardiomyopathy Drug Sales Forecast 2019-2025 (MT)
Table Central & South America Canine Dilated Cardiomyopathy Drug Sales Forecast by Countries 2019-2025 (MT)
Table Central & South America Canine Dilated Cardiomyopathy Drug Sales Market Share Forecast by Countries 2019-2025
Table Central & South America Canine Dilated Cardiomyopathy Drug Revenue Forecast by Countries 2019-2025 (Million US$)
Table Central & South America Canine Dilated Cardiomyopathy Drug Revenue Market Share Forecast by Countries 2019-2025
Figure Brazil Canine Dilated Cardiomyopathy Drug Sales Forecast 2019-2025 (MT)
Table Middle East and Africa Canine Dilated Cardiomyopathy Drug Sales Forecast by Regions 2019-2025 (MT)
Table Middle East and Africa Canine Dilated Cardiomyopathy Drug Sales Market Share Forecast by Regions 2019-2025
Table Middle East and Africa Canine Dilated Cardiomyopathy Drug Revenue Forecast by Regions 2019-2025 (Million US$)
Table Middle East and Africa Canine Dilated Cardiomyopathy Drug Revenue Market Share Forecast by Regions 2019-2025
Figure Turkey Canine Dilated Cardiomyopathy Drug Sales Forecast 2019-2025 (MT)
Figure GCC Countries Canine Dilated Cardiomyopathy Drug Sales Forecast 2019-2025 (MT)
Figure Egypt Canine Dilated Cardiomyopathy Drug Sales Forecast 2019-2025 (MT)
Figure South Africa Canine Dilated Cardiomyopathy Drug Sales Forecast 2019-2025 (MT)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

以下、関連資料のご紹介
  • 世界の犬用拡張型心筋症薬産業調査2019-2025
    Global Canine Dilated Cardiomyopathy Drug Industry Research Report, Growth Trends and Competitive Analysis 2019-2025
    QYR9NV15385 2019年11月16日 117Pages
    ※本調査レポートでは、世界の犬用拡張型心筋症薬市場について調査・分析し、市場規模、市場動向、市場予測（～2025年）、市場シェア、関連企業情報などを含め、以下の構成でお届け致します。犬用拡張型心筋症薬の種類別には、経口、注射剤に、用途別には、オンライン、オフラインに、地域別には、北米、アメリカ、ヨー...
  • 拡張型心筋症治療薬のグローバル市場：規模・現状・予測2019-2025
    Global Dilated Cardiomyopathy Therapeutics Market Size, Status and Forecast 2019-2025
    QYR9NV17850 2019年11月18日 92Pages
    ※当調査レポートでは、拡張型心筋症治療薬の世界市場について調査・分析し、拡張型心筋症治療薬の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（薬物クラス、植込み型デバイス、パイプライン分析）、用途別（病...
  • 拡張型心筋症治療薬のグローバル市場：規模・現状・予測2019-2025
    Global Dilated Cardiomyopathy Therapeutics Market Size, Status and Forecast 2019-2025
    QYR9NV17850 2019年11月18日 92Pages
    ※当調査レポートでは、拡張型心筋症治療薬の世界市場について調査・分析し、拡張型心筋症治療薬の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（薬物クラス、植込み型デバイス、パイプライン分析）、用途別（病...
  • 犬用インフルエンザワクチンのグローバル市場調査 2019年
    Global Canine Influenza Vaccine Market Professional Survey Report 2019
    QYR9NV02119 2019年11月12日 109Pages
    ※本調査レポートは、犬用インフルエンザワクチンの世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、液体、粉末に、用途別には、ホーム、ペットクリニック、その他にセグ...
  • 血栓溶解薬のグローバル市場：規模・現状・予測2019-2025
    Global Thrombolytic Drug Market Size, Status and Forecast 2019-2025
    QYR9NV18486 2019年11月18日 91Pages
    ※当調査レポートでは、血栓溶解薬の世界市場について調査・分析し、血栓溶解薬の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（フィブリン特異的薬物、非フィブリン特異的薬物シブ、シムツズマブ、INCB-3...
  • 血栓溶解薬のグローバル市場：規模・現状・予測2019-2025
    Global Thrombolytic Drug Market Size, Status and Forecast 2019-2025
    QYR9NV18486 2019年11月18日 91Pages
    ※当調査レポートでは、血栓溶解薬の世界市場について調査・分析し、血栓溶解薬の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（フィブリン特異的薬物、非フィブリン特異的薬物シブ、シムツズマブ、INCB-3...
  • 創薬ソフトウェアのグローバル市場：規模・現状・予測2019-2025
    Global Drug Discovery Software Market Size, Status and Forecast 2019-2025
    QYR9NV17871 2019年11月18日 91Pages
    ※当調査レポートでは、創薬ソフトウェアの世界市場について調査・分析し、創薬ソフトウェアの世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（クラウドベース、ウェブベース）、用途別（CRO及び大学、企業、試...
  • 創薬ソフトウェアのグローバル市場：規模・現状・予測2019-2025
    Global Drug Discovery Software Market Size, Status and Forecast 2019-2025
    QYR9NV17871 2019年11月18日 91Pages
    ※当調査レポートでは、創薬ソフトウェアの世界市場について調査・分析し、創薬ソフトウェアの世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（クラウドベース、ウェブベース）、用途別（CRO及び大学、企業、試...
  • 世界のシロアリ薬産業調査2019-2025
    Global Termite Drug Industry Research Report, Growth Trends and Competitive Analysis 2019-2025
    QYR9NV17306 2019年11月18日 119Pages
    ※本調査レポートでは、世界のシロアリ薬市場について調査・分析し、市場規模、市場動向、市場予測（～2025年）、市場シェア、関連企業情報などを含め、以下の構成でお届け致します。シロアリ薬の種類別には、ビフェントリン、ホウ酸塩、フッ化スルフリル、その他に、用途別には、商業、住宅、農業、その他に、地域別に...
  • 薬物検査ソフトウェアのグローバル市場：規模・現状・予測2019-2025
    Global Drug Testing Software Market Size, Status and Forecast 2019-2025
    QYR9NV17872 2019年11月18日 129Pages
    ※当調査レポートでは、薬物検査ソフトウェアの世界市場について調査・分析し、薬物検査ソフトウェアの世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（クラウドベース、ウェブベース）、用途別（大企業、中小企業...